Sirna Therapeutics, Galapagos, Asinex, Invitrogen, Caltag Laboratories, Qiagenn, Procognia

May 20, 2005

Premium

Sirna Restructuring Detailed in SEC Filing;
Company Lays Off Eleven

Sirna Therapeutics said this week in a filing with the US Securities and Exchange Commission that its previously announced layoffs included the termination of 11 employees.

According to the company, the layoffs resulted in an annualized salary and benefits savings of $2.1 million. Severance and other costs related to the reduction in force will be $350,000, Sirna noted in the filing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Menu